Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.41−0.13 (-5.12%)
Close on Nov 18, 2026Market cap $9.34MP/E –Yield –
Sunshine Biopharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Sunshine Biopharma's pe ratio was 0.0× on Jan 31, 2012.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2012 | Jan 31, 2012 | 0.0× | −0.0 |
| 2011 | Dec 30, 2011 | 0.0× | – |
See a number that looks wrong?